Ceftazidime, carbapenems, or piperacillin-tazobactam for Pseudomonas aeruginosa bloodstream infection?
Ceftazidime, carbapenems, or piperacillin-tazobactam as single definitive therapy for Pseudomonas aeruginosa bloodstream infection - a multi-site retrospective study.
Rédigé par : Dr Jean-Pierre Bru
The optimal empirical and definitive antibiotic regimens for the treatment of Pseudomonas aeruginosa infections are yet to be defined. One of the questions involves the use of combination vs. monotherapy regimens. Current data demonstrate no mortality benefit using two active antipseudomonal agents over a single active agent as definitive therapy. Another unresolved question is whether any spec...
Ce contenu est à destination des professionnels de santé. Merci de vous identifier.
This content is intended for healthcare professionals. Thank you for identifying yourself.
This content is intended for healthcare professionals. Thank you for identifying yourself.
Déjà inscrit / Already registered ?
Créer un compte / Create an account
Créer un compte ne prend que quelques minutes et vous permettra d'accèder à l'ensemble des contenus du site.
Creating an account takes only instant and will allow you to access all the content of the website.